User:Karmella Haynes/Notebook/Polycomb project/2010/06/02

{| width="800"
 * style="background-color: #EEE"|[[Image:owwnotebook_icon.png|128px]] Project name
 * style="background-color: #F2F2F2" align="center"|  |Main project page
 * style="background-color: #F2F2F2" align="center"|  |Main project page


 * colspan="2"|
 * colspan="2"|

06/02/10

 * &#x2713; KAH130-2: thawed cells barely growing; some colonies; refresh 20% FBS medium
 * &#x2713; Senescence assay: plan optimization
 * &#x2713; Growth assay: split cell lines 1:10 in 10 cm plates; 1 +ab's, 1 plain med., 1 plain med. + 1μg/mL dox (refresh every 2 days) (starting over, throw out old overgrown plates)

Senescence assay > Flow cytometry based method using C12-FDG; based on Noppe et al. (Cytometry, 2009) and Kurz et al. (J or Cell Sci, 2000) --> pH modulation; appears to be essential only for X-gal method (not C12-FDG) --> Step 2: Rotenone treatment (senescence inducer); working concentration = 0.2 μg/mL (~0.6 μM), >3 days --> Step 3: C12-FDG treatment; working concentration = 30 μg/mL (~33 μM), 1 hour --> Step 4: visualize w/ FITC microscope setting or harvest for flow cytometry (500-510 nm wavelength)

> Stock solutions --> 50x C12-FDG: 5 mg C12-FDG in 3.3 mL 70% DMSO/PBS* (1.5 mg/mL); Aliquot and store @ -20°C --> 10,000x rotenone: 10 mg rotenone in 5 mL 100% DMSO (2.0 mg/mL); make 1000x rotenone, aliquot, store @ -20°C

*Accidentally added 1 mL PBS before realizing C12-FDG is not soluble in H2O. Solubility appears okay in 70% DMSO.


 * }